1 |
Advanced stage of development (typically preclinical or later) |
Advanced-stage collaborations have higher chances of successfully completing all phases of development. |
2 |
Addresses an unmet medical need |
Such projects have greater likelihood of receiving funding or being transferred to an appropriate partner, such as a PDP or company, for continued development. |
3 |
Novel target or approach |
Such collaborations have greater potential to lead to innovative products that address unmet needs. |
4 |
Aligns with published target product profiles (TPPs) or target candidate profiles (TCPs) (e.g., [21,22]) |
TPPs and TCPs define experts’ standards and expected needs for on-the-ground product use. By aligning with TPP or TCP criteria, a product is more likely to meet experts’ standards and be accessible and acceptable for use in endemic regions. |
5 |
Exemplifies the use of IP as an enabler of innovation, or demonstrates a company’s commitment to improving access to medicines |
WIPO Re:Search has two core goals: to accelerate product development for diseases of poverty, and to demonstrate that IP is not a barrier to access to medicines. Projects that fulfill this criterion exemplify the latter goal. |